The online version of this article (doi:10.1186/1475-2867-12-32) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
ZSH participated in the design of the study, carried out all the studies and drafted the manuscript. 2) XP conceived of the study, provided all the funds, participated in its design and coordination and helped to draft and revise the manuscript. 3) WHY, LYY, LYL and JH participated in the animal study and involved in drafting the manuscript. All authors read and approved the final manuscript.
EPCs were isolated primarily in 1997 by Asahara et al. and recent studies indicated that bone-marrow-derived EPCs contributed little to the endothelium of tumor vessels. Tumors of the CNS system demonstrate various features of angiogenesis.
EPCs derived from rat bone marrow were isolated and cultured in M199 medium without any induced factors. EPCs were studied using immunohistochemical staining, Flow cytometry and culture under three-dimensional condition to determine EPCs’ characteristics in vitro. We also established an animal model by injecting EPCs marked with Hoechst 33342 into the back of BALB/c nude mice and performed hematoxylin-eosin (HE) and immunofluorescent staining to study EPCs’ features in vivo. To research effect of EPCs on glioma, animals bearing tumors model with C6 glioma were established. About 27 day after injection, we performed immunohistochemical staining and Immunofluorescence staining.
Our results showed that EPCs derived from rat bone marrow appeared typical morphological characteristics and were positive of CD34, CD133, KDR and CD31 antigens at different time in vitro under the special M199 medium without any induced factors. The percentage of cells that expressed CD133 decreased gradually. In brief, the present study showed that EPCs derived from rat bone marrow differentiated into ECs in medium the without any induced factors and formed tubular structures in three-dimensional circumstances. Animal experiments suggested that EPCs differentiated into ECs and other else non-endothelial cells, and that EPCs contributed M199 of glioma.
These findings provides some novel results about biological characteristics of EPCs in vivo and ex vivo, and an update on the effect of EPCs on glioma and which would be helpful for the overall understanding of EPCs and make EPCs to be implied on the clinical therapy.
Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A: Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis. 2008, 97: 496-503. CrossRef
Isikawa H, Ishi K, Werna VA: Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology. 2010, 151 (6): 2433-2442. 10.1210/en.2009-1225. CrossRef
Ueno H, Koyama H, Fukumoto S: Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease. Metabolism. 2011, 60: 439-453. CrossRef
Cianciolo G, La manna G, Cappuccilli ML: VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy. Blood Purify. 2011, 32 (3): 161-173. 10.1159/000325459. CrossRef
Schiffer D, Chio A, Giordana M: The vascular response to tumor infiltration in malignant gliomas. Acta Neuropathol (Berl). 1989, 77: 369-378. 10.1007/BF00687371. CrossRef
Vernon RB, Angello JC, Iruela-Arispe ML, Lane TF, Sage EH: Reorganization of basement membrane matrices by cellular traction promotes the formation of cellular networks in vitro. Lab Investig. 1992, 66: 536-547. PubMed
- The characteristics of bone marrow-derived endothelial progenitor cells and their effect on glioma
- BioMed Central
Neu im Fachgebiet Onkologie
Mail Icon II